MeVis Medical Solutions Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for MeVis Medical Solutions.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare Services earnings growth | 30.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation
Nov 30
Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable
Mar 16MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward
Feb 14Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?
Feb 22MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Feb 01
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MeVis Medical Solutions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 18 | 6 | N/A | N/A | N/A |
| 12/31/2023 | 17 | 5 | N/A | N/A | N/A |
| 9/30/2023 | 17 | 5 | 6 | 6 | N/A |
| 6/30/2023 | 18 | 6 | N/A | N/A | N/A |
| 3/31/2023 | 19 | 6 | N/A | N/A | N/A |
| 12/31/2022 | 19 | 7 | N/A | N/A | N/A |
| 9/30/2022 | 19 | 8 | 5 | 5 | N/A |
| 6/30/2022 | 18 | 7 | N/A | N/A | N/A |
| 3/31/2022 | 17 | 6 | N/A | N/A | N/A |
| 12/31/2021 | 16 | 5 | N/A | N/A | N/A |
| 9/30/2021 | 16 | 5 | 9 | 9 | N/A |
| 6/30/2021 | 16 | 5 | N/A | N/A | N/A |
| 3/31/2021 | 17 | 5 | N/A | N/A | N/A |
| 12/31/2020 | 17 | 5 | N/A | N/A | N/A |
| 9/30/2020 | 17 | 6 | 3 | 3 | N/A |
| 6/30/2020 | 18 | 7 | N/A | N/A | N/A |
| 3/31/2020 | 18 | 7 | N/A | N/A | N/A |
| 12/31/2019 | 18 | 7 | N/A | N/A | N/A |
| 9/30/2019 | 18 | 8 | 6 | 7 | N/A |
| 6/30/2019 | 19 | 8 | 7 | 7 | N/A |
| 3/31/2019 | 18 | 9 | 4 | 4 | N/A |
| 12/31/2018 | 17 | 8 | 6 | 6 | N/A |
| 9/30/2018 | 18 | 8 | 5 | 5 | N/A |
| 6/30/2018 | 16 | 7 | 5 | 6 | N/A |
| 3/31/2018 | 17 | 4 | 7 | 7 | N/A |
| 12/31/2017 | 17 | 3 | N/A | 7 | N/A |
| 9/30/2017 | 19 | 6 | N/A | 7 | N/A |
| 6/30/2017 | 19 | 5 | N/A | 7 | N/A |
| 3/31/2017 | 18 | 7 | N/A | 6 | N/A |
| 12/31/2016 | 18 | 8 | N/A | 4 | N/A |
| 9/30/2016 | 16 | 7 | N/A | 7 | N/A |
| 6/30/2016 | 17 | 7 | N/A | 6 | N/A |
| 3/31/2016 | 16 | 6 | N/A | 7 | N/A |
| 12/31/2015 | 16 | 7 | N/A | 7 | N/A |
| 9/30/2015 | 15 | 3 | N/A | 6 | N/A |
| 6/30/2015 | 15 | 3 | N/A | 5 | N/A |
| 3/31/2015 | 14 | 4 | N/A | 6 | N/A |
| 12/31/2014 | 14 | 4 | N/A | 5 | N/A |
| 9/30/2014 | 14 | 4 | N/A | 6 | N/A |
| 6/30/2014 | 14 | 4 | N/A | 8 | N/A |
| 3/31/2014 | 14 | 4 | N/A | 7 | N/A |
| 12/31/2013 | 14 | 4 | N/A | 8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if M3V's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if M3V's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if M3V's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if M3V's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if M3V's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if M3V's Return on Equity is forecast to be high in 3 years time